IFP Advisors’s Citius Pharmaceuticals CTXR Stock Holding History

IFP Advisors’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.22K	Hold	4,183	–	–	﹤0.01%	4178
2026 Q2	$2.53K	Sell	4,183 -2,900	-41%	-$1.96K	﹤0.01%	4130
2026 Q1	$6.38K	Hold	7,083	–	–	﹤0.01%	3391
2025 Q4	$5.5K	Hold	7,083	–	–	﹤0.01%	3366
2025 Q3	$8.78K	Hold	7,083	–	–	﹤0.01%	2965
2025 Q2	$11.3K	Hold	7,083	–	–	﹤0.01%	2839
2025 Q1	$10.6K	Sell	7,083 -33,333	-82%	-$79.8K	﹤0.01%	2563
2024 Q4	$32.8K	Buy	40,416 +39,083	+2,932%	+$263K	﹤0.01%	2039
2024 Q3	$16.7K	Buy	+1,333	New	+$22.4K	﹤0.01%	2216
2023 Q1	–	Sell	-8	Closed	-$1K	–	3582
2022 Q4	$1K	Hold	8	–	–	﹤0.01%	4310
2022 Q3	$1K	Hold	8	–	–	﹤0.01%	4527
2022 Q2	$1K	Hold	8	–	–	﹤0.01%	4307
2022 Q1	$1K	Buy	+8	New	+$316	﹤0.01%	4307

Other funds holding CTXR

AAG

Asset Advisory Group Kinnelon, New Jersey $232M AUM 16.51% 1-Year Est. Return

IFP Advisors's CTXR Position: Q3 2026 in Review

IFP Advisors held its Citius Pharmaceuticals (CTXR) position steady in Q3 2026 at 4,183 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #4178.

IFP Advisors first reported a position in CTXR in Q1 2022 and has held it in 13 quarters since. The position peaked at $32.8K in Q4 2024. 2 funds tracked by Wall St. Rank hold CTXR as of Q3 2026.

IFP Advisors held 4,183 shares of Citius Pharmaceuticals worth $2.22K as of Q3 2026.
IFP Advisors left its Citius Pharmaceuticals share count unchanged in Q3 2026.
Citius Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4178 holding.
IFP Advisors first reported a position in Citius Pharmaceuticals in Q1 2022 and has held it in 13 quarters since.
IFP Advisors's Citius Pharmaceuticals position peaked at $32.8K in Q4 2024.
2 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.